医生沟通式放疗计划复核对乳腺癌患者报告满意度影响的前瞻性随机对照试验
该前瞻性随机试验将64例I-III期乳腺癌辅助放疗患者分为标准非详细复核组(A组37例)与放疗第1周深度个体化计划复核组(B组27例),使用FACIT-TS-PS问卷评估医生沟通、技术能力、信心与信任及总体满意度。两组的基线评分均较高,三个时间点的各维度评分均无显著差异。
要点
- 深度个体化放疗计划复核未显著改变乳腺癌患者报告满意度评分。
- 两组基线及干预后各满意度维度评分均较高,组间无显著差异。
- 需更细致评估与沟通类型分析以捕捉患者报告结局的细微差异。
核心结论
- 医生沟通式深度放疗计划复核未显著改善乳腺癌辅助放疗患者的报告满意度。
- 两组各满意度维度在基线及干预后评分均较高,三个时间点无显著差异。
研究设计与样本
- 前瞻性随机对照试验,2014年3月至2016年3月纳入64例I-III期乳腺癌辅助放疗患者,A组37例接受标准非详细复核,B组27例接受放疗第1周深度个体化计划复核。
- 计划复核内容包括治疗计划可视化、放疗剂量、射束布置、正常组织剂量及剂量/体积约束。
- 采用FACIT-TS-PS问卷子集评估医生沟通、技术能力、信心与信任及总体满意度,比较基线、第1周和放疗结束时的平均评分差异。
主要发现
- 基线医生沟通、技术能力、信心与信任及总体满意度平均分分别为2.73(SD 0.71)、2.66(SD 0.86)、2.56(SD 0.98)和2.27(SD 0.88),两组基线评分均较高。
- 两组基线报告沟通指标无差异。
- 医生沟通、技术能力、信心与信任及总体满意度在三个时间点间均无显著差异(P值分别为.63、.53、0.52和0.71)。
临床怎么用
- 深度个体化放疗计划复核可作为医患沟通选项,但本试验未显示其能显著提升患者报告满意度。
- 临床沟通优化可能需要更细致的患者评估和对沟通类型及信息处理的理解。
局限性
- 样本量较小(共64例,A组37例、B组27例),可能不足以检出患者报告结局的细微差异。
- 两组基线满意度评分均较高,可能存在天花板效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Patients with breast cancer face complex medical decision-making. We investigated the impact of a physician-communicated, patient-specific radiation therapy (RT) plan review on patient-reported outcomes (PROs) for patients with breast cancer receiving adjuvant RT in a prospective randomized trial. METHODS AND MATERIALS: Patients with stage I-III breast cancer treated with adjuvant RT were prospectively randomized to a standard nondetailed review (Arm A) versus an in-depth, individualized RT plan review during week 1 of RT (Arm B). Plan review included visualization of the treatment plan, RT doses, beam arrangements, normal tissue doses, and dose/volume constraints. Patient-reported satisfaction was assessed using a subset of the Functional Assessment of Chronic Illness Therapy - Treatment Satisfaction - Patient Satisfaction questionnaire related to physician communication (PC), technical competency (TC), confidence and trust (C&T), and overall satisfaction (OS). The difference in mean scores at baseline, week 1, and the end of RT were assessed. RESULTS: From March 2014 to March 2016, 64 patients with breast cancer (37 in Arm A; 27 in Arm B) were randomized and completed all 3 surveys. Mean baseline scores for PC, TC, C&T, and OS mean were 2.73 (standard deviation [SD], 0.71), 2.66 (SD, 0.86), 2.56 (SD, 0.98), and 2.27 (SD, 0.88), respectively, with high baseline scores in both arms. There was no difference in baseline-reported communication indicators between the arms. There were no significant differences among the 3 time points for PC, TC, C&T, or OS (P = .63, .53, 0.52, and 0.71, respectively). CONCLUSIONS: We report the first randomized trial evaluating the impact of in-depth RT plan review on PROs during breast radiation. Both baseline and postintervention scores were high for all domains. Detailed patient assessment, understanding of communication types, and information processing may be necessary to determine subtle PRO differences. Further investigations of PROs could potentially direct and optimize physician and patient communication during RT.
引用
- Dyer BA, Li CS, Daly ME, et al. Prospective, Randomized Control Trial Investigating the Impact of a Physician-Communicated Radiation Therapy Plan Review on Breast Cancer Patient-Reported Satisfaction. Pract Radiat Oncol. 2019. PMID: 31226443. doi:10.1016/j.prro.2019.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。